AmgenAmgen Assist gives patients and healthcare professionals a single destination for access to eService and online forms, and makes it easier to find a program that would best meet each patient's unique needs, including coverage and reimbursement services, copay support information, and assistance for uninsured patients. Please contact us at (888) 4ASSIST (8884277478), or visit us at www.amgenassistonline.com.
Braftovi + Mektovi Access - Patient Co-Pay Savings Program. Eligible patients may pay as little as $0 per month supply of Braftovi + Mektovi. Activation is simple on the online portal, with no income requirements.
XTANDI Support Solutions can help your patients obtain XTANDI through our network of specialty pharmacies, help problem-solve financial assistance, and provide educational resources included with prescription delivery. To learn more, please call 1-855-989-2634 or visit www.xtandisupportsolutions.com
Astellas also supports Xospata at www.XospataHCP.com or contact Kevin Kobylinski at Kevin.Kobylinski@Astellas.com
ASTRaZENECAAt AstraZeneca, we believe it’s not enough for us to simply make medicines. We have to make sure that the people who need those medicines can get them. It’s why we’ve offered patient assistance programs for over 30 years.
If you are an individual making $30,000 or less or a family of four making $60,000 or less you may qualify for an AZ&Me™ Prescription Savings Program. Go to www.azandme.com for more information.
For assistance with products like Faslodex, Imfinzi, Iressa, Lynparza, and Tagrisso, please consider the following resources:
AstraZeneca Access360: https://www.myaccess360.com/access-360-for-healthcare-professionals-and-patients.html
AstraZeneca Specialty Savings: http://www.azandmeapp.com/resources/specialty_oncology_income_eligibility
Jenifer N. McNulty
Field Reimbursement Manager, MA, ME, NH, VT, CT, and RI
Bristol-Myers Squibb is committed to helping appropriate patients get access to our medications by providing access and reimbursement services.
Access Reimbursement Manager: Dick Bazirgan: (978) 992-2472
Celgene Patient Support Coordinator® Program
A dedicated, central point of contact helping providers and patients identify resources to gain access to Celgene products, including Revlimid®, Thalomid® and Vidaza®. Available to answer your questions Monday–Friday from 8:00 AM to 7:00 PM Eastern Time. 1-800-931-8691
At Coherus Biosciences, we are committed to ensuring that patients have access to biologics such as Udenyca™. Coherus Complete provides patient support services and programs designed to assist with patient access. For more information, please visit https://www.coheruscomplete.com/
Genentech is dedicated to helping patients. Since Genentech started providing access and reimbursement support almost 20 years ago, Genentech has helped more than 1.2 million patients access the medicines they need.
Patient Assistance Programs via Genentech Access Solutions include:
Genentech BioOncology Co-Pay Card - The Genentech BioOncology Co-Pay Card is for commercially insured patients receiving treatment with a Genentech BioOncology product that meet certain eligibility criteria. There are no income requirements. The Annual Benefit limit of the Co-Pay Card is $25,000. Patient pays a $25 co-pay per prescription or infusion.
Co-Pay Assistance Foundations - If privately or publicly insured patients have difficulty paying their co-pay, co-insurance or other expenses, Genentech Access Solutions can refer them to a co-pay assistance foundation supporting their disease.
Genentech Access to Care Foundation (GATCF) - GATCF was established to help patients with unmet medical needs who are uninsured or rendered uninsured by payer denial and who meet specific criteria to receive their prescription free of charge.
For more information, please visit www.genentech-access.com/
For more information on Incyte's Patient Support Programs, please visit http://www.IncyteCares.com
Janssen CarePath: http://www.janssencarepath.com *For assistance regarding Darzalex (daratumumab), Yondelis (trabectedin), Zytiga (abiraterone acetate), Doxil (doxorubicin HCI liposome injection), Procrit (epoetin alfa), and Sylvant (siltuximab)
Janssen's Advocacy Connector: http://advocacyconnector.com
For more information on Lilly's Patient Support Programs, please visit http://www.lillypatientone.com/.
YOU&I™ Support Program is a comprehensive, personalized support program from Pharmacyclics, Inc. and Janssen Biotech, Inc., designed to help make access simple, convenient, and easy. Patients or their provider may access YOU&I™ Support by visiting www.youandisupport.com or calling 1-877-877-3536. YOU&I™ Support consists of two parts: YOU&I™ Start Program which can provide access to our approved drug for patients who are experiencing insurance coverage decision delays; and YOU&I™ Instant Savings which allows patients on commercial insurance, and who meet eligibility requirements, to pay no more than $10 per month for our approved drug. YOU&I™ Support may also be utilized for benefit investigation to determine if our approved drug is covered, or help with prior authorization process at your request. For more information, please click HERE.